WallStreetZenWallStreetZen

NASDAQ: GYRE
Gyre Therapeutics Inc Stock Ownership - Who owns Gyre Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Gyre Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Weiguo YeChief Operating Officer2026-06-112,800$6.17
$17.28kSell
Weiguo YeChief Operating Officer2026-06-112,800$0.75
$2.10kBuy
Weiguo YeChief Operating Officer2026-06-106,418$6.21
$39.86kSell
Weiguo YeChief Operating Officer2026-06-106,418$0.75
$4.81kBuy
Weiguo YeChief Operating Officer2026-06-0914,500$0.75
$10.88kBuy
Weiguo YeChief Operating Officer2026-06-0914,500$6.14
$89.03kSell
Weiguo YeChief Operating Officer2026-06-0515,401$6.40
$98.57kSell
Weiguo YeChief Operating Officer2026-06-0515,401$0.75
$11.55kBuy
Weiguo YeChief Operating Officer2026-06-0419,575$6.13
$119.99kSell
Weiguo YeChief Operating Officer2026-06-0419,575$0.75
$14.68kBuy

1 of 3

GYRE insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when GYRE insiders and whales buy or sell their stock.

GYRE Shareholders

What type of owners hold Gyre Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Gni Group Ltd72.42%70,272,408$439.20MInsider
Bvf Partners L P12.02%11,664,575$72.90MInsider
Nea Partners 10 L P8.07%7,827,024$48.92MInsider
Iii Eugene A. Trainor8.07%7,827,024$48.92MInsider
Investment 10 LLC6.36%6,171,669$38.57MInsider
C. Richard Kramlich4.71%4,572,845$28.58MInsider
Peter J. Barris4.71%4,570,845$28.57MInsider
M. James Barrett4.71%4,570,845$28.57MInsider
Scott D. Sandell4.71%4,569,845$28.56MInsider
Mark W. Perry4.71%4,567,512$28.55MInsider

1 of 3

GYRE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
GYRE2.05%97.95%Net SellingNet Selling
BBOT62.76%37.24%Net BuyingNet Selling
TRAX0.00%24.51%Net SellingNet Selling
CADL59.27%24.06%Net Buying
RIGL39.11%60.89%Net SellingNet Selling
View Top Biotech Stocks

Gyre Therapeutics Stock Ownership FAQ

Who owns Gyre Therapeutics?

Gyre Therapeutics (NASDAQ: GYRE) is owned by 3.51% institutional shareholders, 167.46% Gyre Therapeutics insiders, and 0.00% retail investors. Gni Group Ltd is the largest individual Gyre Therapeutics shareholder, owning 70.27M shares representing 72.42% of the company. Gni Group Ltd's Gyre Therapeutics shares are currently valued at $439.20M.

If you're new to stock investing, here's how to buy Gyre Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.